[HTML][HTML] Global pandemics interconnected—obesity, impaired metabolic health and COVID-19
Obesity and impaired metabolic health are established risk factors for the non-
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …
Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19)
Y Zhou, J Chi, W Lv, Y Wang - Diabetes/metabolism research …, 2021 - Wiley Online Library
The outbreak of the coronavirus disease 2019 (Covid‐19) has become an evolving
worldwide health crisis. With the rising prevalence of obesity and diabetes has come an …
worldwide health crisis. With the rising prevalence of obesity and diabetes has come an …
Emerging telemedicine tools for remote COVID-19 diagnosis, monitoring, and management
The management of the COVID-19 pandemic has relied on cautious contact tracing,
quarantine, and sterilization protocols while we await a vaccine to be made widely available …
quarantine, and sterilization protocols while we await a vaccine to be made widely available …
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta …
Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies
A Mantovani, CD Byrne, MH Zheng… - Nutrition, Metabolism and …, 2020 - Elsevier
Aims To estimate the prevalence of established diabetes and its association with the clinical
severity and in-hospital mortality associated with COVID-19. Data synthesis We …
severity and in-hospital mortality associated with COVID-19. Data synthesis We …
Extrapulmonary complications of COVID‐19: A multisystem disease?
The outbreak of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has been recently declared a pandemic …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has been recently declared a pandemic …
Metformin and COVID-19: from cellular mechanisms to reduced mortality
AJ Scheen - Diabetes & metabolism, 2020 - Elsevier
Type 2 diabetes mellitus (T2DM) is associated with both poorer clinical outcomes during the
COVID-19 pandemic and an increased risk of death in such hospitalized patients. While the …
COVID-19 pandemic and an increased risk of death in such hospitalized patients. While the …
Impact of obesity on COVID-19 patients
W Yu, KE Rohli, S Yang, P Jia - Journal of Diabetes and its Complications, 2021 - Elsevier
With the increasing prevalence of obesity, there is a growing awareness of its impact on
infectious diseases. In past epidemics of influenza A and Middle East respiratory syndrome …
infectious diseases. In past epidemics of influenza A and Middle East respiratory syndrome …
Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis
Introduction To date, COVID‐19 has claimed 4.9 million lives. Diabetes has been identified
as an independent risk factor of serious outcomes in people with COVID‐19 infection …
as an independent risk factor of serious outcomes in people with COVID‐19 infection …
[HTML][HTML] COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality
Diabetes is a condition that affects a large percentage of the population and it is the leading
cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in …
cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in …